Sugi Predict

Sugi Predict / Compounds / SCHEMBL755802

SCHEMBL755802

SCHEMBL755802

Oc1ccc(OCOc2cccc(O)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.51
▸ CHRNA4 P43681 2/20 0.51
▸ APP P05067 1/20 0.51
▸ CHRNB4 P30926 3/20 0.47
▸ CHRNA3 P32297 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ CNR1 P21554 1/20 0.47
▸ CNR2 P34972 1/20 0.47
▸ DRD2 P14416 2/20 0.45
▸ DRD4 P21917 2/20 0.45
▸ DRD3 P35462 2/20 0.45
▸ ADRA1D P25100 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10782254 0.92 CHRNB2 (0.58) CHRNB2CHRNA4APPCHRNB4CHRNA3
SCHEMBL21633693 0.90 DRD2 (0.54) CHRNB2CHRNA4APPCHRNB4CHRNA3
SCHEMBL9127216 0.85 CNR1 (0.62) CHRNB2CHRNA4APPCNR1CNR2
SCHEMBL8452874 0.82 LTA4H (0.56) APPLMNACYP1A2PTGS1SLC6A2
SCHEMBL23975528 0.81 CHRNB2 (0.53) CHRNB2CHRNA4APPCHRNB4CHRNA3
SCHEMBL27735405 0.80 APP (0.77) CHRNB2CHRNA4APPLMNACYP1A2
SCHEMBL3420663 0.80 CHRNB2 (0.56) CHRNB2CHRNA4APPCHRNB4CHRNA3
SCHEMBL16902835 0.79 APP (0.51) CHRNB2CHRNA4APPCHRNB4CHRNA3
SCHEMBL1470185 0.79 CHRNB2 (0.69) CHRNB2CHRNA4APPCHRNB4CHRNA3
SCHEMBL29510932 0.79 CHRNB2 (0.69) CHRNB2CHRNA4APPCHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382588-A1 ADDITIVES FOR IMPROVING THERMAL STABILITY OF FUELS BASF SE (DE) 2024-06-12 — — EP claimed
US-20240217923-A1 A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION BASF (CHINA) COMPANY LIMITED (CN) 2024-07-04 — — US disclosed
EP-4382588-A1 ADDITIVES FOR IMPROVING THERMAL STABILITY OF FUELS BASF SE (DE) 2024-06-12 — — EP disclosed
EP-3906245-B1 MULTIFUNCTIONAL ORGANOSILICON COMPOUND AND RELATED METHODS, COMPOUNDS, AND COMPOSITIONS DOW SILICONES CORP (US) 2024-05-29 — — EP disclosed
EP-4330226-A1 A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION BASF SE (DE) 2024-03-06 — — EP disclosed
WO-2024012851-A1 SUSTAINABLE ANTIOXIDANT COMPOSITION, USE THEREOF AND POLYMER COMPOSITION COMPRISING THE SAME BASF SE (DE) 2024-01-18 — — WO disclosed
CN-117203185-A Diisocyanate stabilizer, use thereof and diisocyanate composition 巴斯夫欧洲公司 2023-12-08 — — CN disclosed
US-11820846-B2 Composition, method of preparing copolymer, and methods and end uses thereof DOW SILICONES CORPORATION (US) 2023-11-21 — — US disclosed
WO-2023201146-A1 PREPARATION OF ORGANOSILICON COMPOUNDS WITH VINYLESTER FUNCTIONALITY DOW GLOBAL TECHNOLOGIES LLC (US) 2023-10-19 — — WO disclosed
US-20230295193-A1 PREPARATION OF MULTIFUNCTIONAL ORGANOSILICON COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC 2023-09-21 — — US disclosed
WO-2004087635-A2 MIXTURES OF COMPOUNDS COMPRISING AT LEAST TWO DOUBLE BONDS AND USE THEREOF BASF AKTIENGESELLSCHAFT (DE) 2004-10-14 — — WO disclosed
EP-1465857-A1 METHOD FOR PRODUCING ACRYLIC ACID BASF AKTIENGESELLSCHAFT (DE) 2004-10-13 — — EP disclosed
US-20040050679-A1 Method for producing (meth) acrylic acid BASF AKTIENGESELLSCHAFT (DE) 2004-03-18 — — US disclosed
WO-2003104302-A1 (METH)ACRYLIC ESTERS OF POLYALKOXYLATED TRIMETHYLOLPROPANE BASF AKTIENGESELLSCHAFT (DE) 2003-12-18 — — WO disclosed
WO-2003104300-A1 (METH)ACRYLIC ESTERS OF POLYALKOXYLATED TRIMETHYLOLPROPANE BASF AKTIENGESELLSCHAFT (DE) 2003-12-18 — — WO disclosed
WO-2003104301-A1 (METH)ACRYLIC ESTERS OF POLYALKOXYLATED GLYCERINE BASF AKTIENGESELLSCHAFT (DE) 2003-12-18 — — WO disclosed
WO-2003099757-A1 STABILISATION OF ETHYLENICALLY UNSATURATED COMPOUNDS COMPRISING HYDROXYLAMINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2003-12-04 — — WO disclosed
WO-2003057657-A1 METHOD FOR PRODUCING ACRYLIC ACID BASF AKTIENGESELLSCHAFT (DE) 2003-07-17 — — WO disclosed
US-20030060654-A1 Preparation of polymerizable compounds BASF AKIENGESELLSCHAFT (DE) 2003-03-27 — — US disclosed
WO-2002051784-A1 METHOD FOR PRODUCING ACRYLIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-07-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820846-B2 Composition, method of preparing copolymer, and methods and end uses thereof BRS3, OXSR1, OXER1 CHRNB2 487/4885CHRNA4 2245/4885APP 3096/4885
US-20230295193-A1 PREPARATION OF MULTIFUNCTIONAL ORGANOSILICON COMPOUNDS SI, CEL, VIP CHRNB2 4135/4885CHRNA4 4735/4885APP 3790/4885
US-20240217923-A1 A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION TST, DDT, PAH CHRNB2 4807/4885CHRNA4 4809/4885APP 3611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.